Abstract:
The present invention concerns cancer biomarkers. In particular, the invention concerns HGF as a biomarker for patient selection and patient prognosis in cancer, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, methods of detection and methods of advertising related thereto.
Abstract:
The present invention is directed to methods for capturing, amplifying and identifying one or more of a plurality of target nucleotide sequences in a sample. The present invention is further directed to a device comprising a solid support having a plurality of wells or pillars and a plurality of oligonucleotides attached to the wells or pillars. Other aspects of the invention are directed to methods of making such devices.
Abstract:
A number of DNA methylation inhibitors are described. The DNA methylation inhibitors were identified using a two-component enhanced green fluorescent protein reporter system to screen a compound library containing procainamide derivatives. The DNA methylation inhibitors can be used for cancer therapy and prevention.
Abstract:
A number of DNA methylation inhibitors are described. The DNA methylation inhibitors were identified using a two-component enhanced green fluorescent protein reporter system to screen a compound library containing procainamide derivatives. The DNA methylation inhibitors can be used for cancer therapy and prevention.
Abstract:
This application relates to compositions comprising whole-tissue potato products with enhanced resistant starch (RS) content and reduced estimated glycemic index values. Methods of preparing and using whole-tissue potato products with enhanced resistant starch (RS) content and glycemic index values are also disclosed.
Abstract:
L'invention concerne un catalyseur, son utilisation pour la conversion électrochimique du méthane en méthanol et pour la conversion électrochimique directe du méthane en CO 2 . Elle concerne également une électrode, en particulier de pile à combustible comprenant un tel catalyseur ainsi qu'un procédé de fabrication d'une telle électrode. Elle concerne encore une pile à combustible comprenant ce catalyseur ou cette électrode. Le catalyseur de l'invention comprend un précurseur de platine (II), et optionnellement un précurseur d'ion(s) métallique(s) M supporté(s) sur des particules d'un hétéropolyanion HPA. L'invention trouve application dans le domaine de l'oxydation électrochimique du méthane en méthanol ou en CO 2 , en particulier.
Abstract:
Systems, methods, and other embodiments associated with producing spatially varying spectral response calibration data are described. One example method includes controlling a digital camera to capture characteristic data arrays from light sensors in the digital camera in response to the digital camera being exposed to light stimuli from a multi-spectral reference display. The data arrays will be acquired multiple times at multiple locations in multiple stimuli provided from the multi-spectral reference display. The method also includes controlling a calibration logic to manipulate characteristic data arrays to produce spatially varying spectral response calibration data as a function of using characteristic data arrays and known wavelengths of the light in light stimuli. The method may also include providing the spatially varying spectral response calibration data to a downstream consumer (e.g., correction process, quality control process), displaying the data, or storing the data.
Abstract:
The present disclosure relates generally to compositions and methods for treating cancer. In some aspects, novel spirohexenolides and methods of using and producing them are described.